CNR1 and depressive symptom measurement: The CB1r synthetic agonist arachidonyl-2′-chloroethylamide (ACEA; 10 mg/kg, i.p.)increased sucrose consumption in post-stroke depression rats, suggesting decreased anhedonia [107]; post-stroke depression is one of the most common psychological consequences of stroke.